Opportunity Overview
SUNY Stony Brook University Hospital posted CR 2138905 — TiCrypt Secure Enclave in the New York State Contract Reporter on September 11, 2026. The authoritative open-opportunities listing classifies it as an Information Technology general procurement.
Verified Procurement Facts
The listed issuer is the State University of New York (SUNY), SUNY Stony Brook University Hospital. The opportunity was issued September 11, 2026 and the controlling public Contract Reporter listing gives a due date of October 2, 2026.
Value, Eligibility and Submission Controls
The accessible authoritative listing does not publish an applicant-relevant contract value, response clock time or time zone, detailed bidder qualifications, pricing structure, required forms or attachments, security terms, insurance requirements, submission mechanics, procurement contacts, or amendment history. Match/cost share is not established as an applicable concept for this procurement. Atlas will not infer any of these controls. Prospective respondents should retrieve the complete Stony Brook solicitation and all amendments before treating the opportunity as bid-ready.
Atlas Fit Analysis
Atlas Opportunity Score: 74/100. This is current New York academic-medical-center IT procurement intelligence, but the verified notice is narrowly titled around a named secure-enclave platform and does not establish a Dr. Miltie role.
N9+ Fit Score: 0/100. The Nonagon N9+ remote physical examination platform is not a secure research-computing enclave and should not be force-fit. QC Healthcare Fit: 0/100. No physician-services or clinical-staffing scope is established by the verified notice.
Realistic Vendor Profile
The title points to the tiCrypt Secure Enclave platform. Tera Insights identifies tiCrypt as its secure research-enclave technology. The realistic respondent set therefore appears to center on the platform provider and any reseller or integration partner that the controlling SUNY solicitation expressly authorizes. This is contextual vendor identification, not a substitute for the solicitation’s bidder-eligibility rules.
Direct-Vendor Assessment
There is no verified evidence that Dr. Miltie/QC Healthcare is an authorized tiCrypt reseller, integrator, or otherwise eligible direct vendor for this procurement. No direct submission or outreach should be advanced unless the controlling package establishes a legitimate role.
Next Action
Retrieve the complete SUNY Stony Brook solicitation and amendments; verify the exact deadline time and time zone, value, specifications, bidder eligibility, security and implementation requirements, pricing, required forms and attachments, contacts, and submission mechanics before any bid action.
Official source: New York State Contract Reporter, CR 2138905.